Cancer Doctors Join Insurers in U.S. Drug-Cost Revolt
Bloomberg reports on how the backlash over surging drug prices is starting to take hold. With the average cost of branded cancer drugs doubling over the past decade to about $10,000 per month in the U.S., doctors, insurers and politicians are all moving in different directions to pressure drug-makers on pricing. Cancer doctors, in particular, are in the process of creating a way to measure the value of the drugs they prescribe. This is but first step in a drive to give patients more affordable options. Drug-makers are forced to step into the breach for consumers who can’t afford their products, prompted by insurers who are increasingly paying only a percentage of the cost of high-priced drugs. Politicians, meanwhile, have begun asking drug-makers to explain the cost of their products…
To read more, click here.
(Image source)
